Garderet, L., & Schönland, S. (2020). Are autologous stem cell transplants still required to treat myeloma in the era of novel therapies?: A review from the chronic malignancies working party of the EBMT. Biology of blood and marrow transplantation, 26(9), . https://doi.org/10.1016/j.bbmt.2020.04.016
Chicago Style (17th ed.) CitationGarderet, Laurent, and Stefan Schönland. "Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies?: A Review from the Chronic Malignancies Working Party of the EBMT." Biology of Blood and Marrow Transplantation 26, no. 9 (2020). https://doi.org/10.1016/j.bbmt.2020.04.016.
MLA (9th ed.) CitationGarderet, Laurent, and Stefan Schönland. "Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies?: A Review from the Chronic Malignancies Working Party of the EBMT." Biology of Blood and Marrow Transplantation, vol. 26, no. 9, 2020, https://doi.org/10.1016/j.bbmt.2020.04.016.